Mesoblast Limited (ASX:MSB – Get Free Report) insider Jane Bell acquired 233,918 shares of the business’s stock in a transaction dated Friday, April 12th. The shares were bought at an average cost of A$0.86 ($0.55) per share, for a total transaction of A$199,999.89 ($129,032.19).
Mesoblast Price Performance
The company has a current ratio of 2.71, a quick ratio of 1.82 and a debt-to-equity ratio of 23.98.
About Mesoblast
Featured Stories
- Five stocks we like better than Mesoblast
- What is the Australian Securities Exchange (ASX)
- Comprehensive Analysis of PayPal Stock
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Upcoming IPO Stock Lockup Period, Explained
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.